Barclays’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.17M | Buy |
127,579
+74,740
| +141% | +$3.03M | ﹤0.01% | 1598 |
|
|
2025
Q1 | $2.72M | Sell |
52,839
-21,825
| -29% | -$1.12M | ﹤0.01% | 1828 |
|
|
2024
Q4 | $4.13M | Sell |
74,664
-23,999
| -24% | -$1.33M | ﹤0.01% | 1736 |
|
|
2024
Q3 | $3.25M | Buy |
98,663
+76,538
| +346% | +$2.52M | ﹤0.01% | 1834 |
|
|
2024
Q2 | $600K | Sell |
22,125
-8,183
| -27% | -$222K | ﹤0.01% | 2429 |
|
|
2024
Q1 | $1.1M | Sell |
30,308
-16,951
| -36% | -$616K | ﹤0.01% | 2338 |
|
|
2023
Q4 | $957K | Buy |
47,259
+35,622
| +306% | +$721K | ﹤0.01% | 2623 |
|
|
2023
Q3 | $206K | Sell |
11,637
-3,319
| -22% | -$58.8K | ﹤0.01% | 3018 |
|
|
2023
Q2 | $270K | Buy |
14,956
+441
| +3% | +$7.96K | ﹤0.01% | 2948 |
|
|
2023
Q1 | $183K | Buy |
14,515
+6,597
| +83% | +$83.2K | ﹤0.01% | 3203 |
|
|
2022
Q4 | $116K | Buy |
7,918
+4,157
| +111% | +$60.9K | ﹤0.01% | 3381 |
|
|
2022
Q3 | $64K | Sell |
3,761
-131
| -3% | -$2.23K | ﹤0.01% | 3579 |
|
|
2022
Q2 | $57K | Buy |
3,892
+1,299
| +50% | +$19K | ﹤0.01% | 3683 |
|
|
2022
Q1 | $44K | Buy |
+2,593
| New | +$44K | ﹤0.01% | 4051 |
|